Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Critical Pathways | 1 | 2022 | 473 | 0.610 |
Why?
|
Cardiology | 3 | 2023 | 1667 | 0.550 |
Why?
|
Cardiovascular System | 1 | 2023 | 835 | 0.500 |
Why?
|
Aorta, Abdominal | 1 | 2017 | 625 | 0.460 |
Why?
|
Aortic Diseases | 1 | 2017 | 735 | 0.370 |
Why?
|
Cardiovascular Diseases | 8 | 2023 | 15399 | 0.370 |
Why?
|
Cardiovascular Agents | 1 | 2017 | 839 | 0.360 |
Why?
|
Critical Care | 1 | 2022 | 2692 | 0.330 |
Why?
|
Coronary Artery Disease | 4 | 2017 | 6362 | 0.280 |
Why?
|
Drugs, Essential | 2 | 2018 | 70 | 0.280 |
Why?
|
Coronary Vessels | 1 | 2017 | 3072 | 0.250 |
Why?
|
Hypertension | 6 | 2024 | 8499 | 0.250 |
Why?
|
Calcium | 1 | 2017 | 5721 | 0.220 |
Why?
|
Social Class | 1 | 2012 | 1999 | 0.220 |
Why?
|
Aortic Valve Stenosis | 2 | 2024 | 2002 | 0.180 |
Why?
|
Insurance Benefits | 1 | 2021 | 188 | 0.170 |
Why?
|
Myocarditis | 2 | 2022 | 766 | 0.170 |
Why?
|
Healthcare Disparities | 4 | 2024 | 3364 | 0.160 |
Why?
|
Africa South of the Sahara | 1 | 2022 | 743 | 0.160 |
Why?
|
Antihypertensive Agents | 3 | 2022 | 2016 | 0.140 |
Why?
|
Income | 2 | 2023 | 1872 | 0.140 |
Why?
|
Drug Compounding | 1 | 2017 | 246 | 0.130 |
Why?
|
Aortic Valve | 2 | 2024 | 1950 | 0.130 |
Why?
|
Medicare | 3 | 2024 | 6741 | 0.130 |
Why?
|
Aortography | 1 | 2017 | 420 | 0.120 |
Why?
|
World Health Organization | 2 | 2018 | 1312 | 0.120 |
Why?
|
Blood Pressure | 2 | 2021 | 8451 | 0.110 |
Why?
|
Coronary Angiography | 2 | 2017 | 4451 | 0.110 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2024 | 1547 | 0.110 |
Why?
|
Blood Pressure Determination | 1 | 2017 | 634 | 0.110 |
Why?
|
Sex Characteristics | 1 | 2023 | 2621 | 0.100 |
Why?
|
Prevalence | 3 | 2022 | 15651 | 0.100 |
Why?
|
Frail Elderly | 1 | 2018 | 751 | 0.100 |
Why?
|
Health Status Indicators | 1 | 2018 | 970 | 0.100 |
Why?
|
Health Status | 2 | 2023 | 4071 | 0.100 |
Why?
|
Health Records, Personal | 1 | 2013 | 127 | 0.100 |
Why?
|
Reimbursement Mechanisms | 1 | 2017 | 663 | 0.090 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5331 | 0.090 |
Why?
|
Stroke | 3 | 2018 | 9694 | 0.090 |
Why?
|
Drug Combinations | 1 | 2017 | 2020 | 0.090 |
Why?
|
Secondary Prevention | 1 | 2017 | 1474 | 0.090 |
Why?
|
Developing Countries | 1 | 2023 | 2866 | 0.090 |
Why?
|
Drug Approval | 1 | 2017 | 808 | 0.090 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11424 | 0.080 |
Why?
|
Primary Prevention | 1 | 2017 | 1185 | 0.080 |
Why?
|
Program Evaluation | 1 | 2018 | 2492 | 0.080 |
Why?
|
Life Style | 2 | 2018 | 3886 | 0.080 |
Why?
|
Complex Mixtures | 1 | 2008 | 29 | 0.080 |
Why?
|
Humans | 25 | 2024 | 758406 | 0.070 |
Why?
|
Forecasting | 1 | 2017 | 2923 | 0.070 |
Why?
|
Comprehension | 1 | 2013 | 619 | 0.070 |
Why?
|
United States | 9 | 2024 | 72136 | 0.070 |
Why?
|
Documentation | 1 | 2013 | 892 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3018 | 0.070 |
Why?
|
Employment | 1 | 2012 | 1112 | 0.070 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2012 | 1730 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2359 | 0.060 |
Why?
|
Hospitalization | 2 | 2023 | 10652 | 0.060 |
Why?
|
Incidence | 3 | 2018 | 21272 | 0.060 |
Why?
|
Curriculum | 1 | 2018 | 3717 | 0.060 |
Why?
|
Health Personnel | 1 | 2018 | 3312 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8823 | 0.060 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2010 | 818 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5404 | 0.060 |
Why?
|
Public Health | 1 | 2017 | 2658 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2012 | 2189 | 0.050 |
Why?
|
Disease Progression | 2 | 2018 | 13468 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3867 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3175 | 0.050 |
Why?
|
Chlorthalidone | 1 | 2022 | 21 | 0.050 |
Why?
|
Male | 13 | 2024 | 358747 | 0.050 |
Why?
|
Lisinopril | 1 | 2022 | 55 | 0.050 |
Why?
|
Linear Models | 1 | 2012 | 5862 | 0.050 |
Why?
|
Amlodipine | 1 | 2022 | 84 | 0.050 |
Why?
|
Female | 13 | 2024 | 390323 | 0.050 |
Why?
|
Primary Health Care | 1 | 2018 | 4652 | 0.050 |
Why?
|
Middle Aged | 9 | 2024 | 219568 | 0.050 |
Why?
|
Aged | 10 | 2024 | 168218 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15225 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2008 | 2189 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10146 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2013 | 3586 | 0.040 |
Why?
|
Health Status Disparities | 2 | 2021 | 1831 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39059 | 0.040 |
Why?
|
Time Factors | 2 | 2021 | 39872 | 0.040 |
Why?
|
Risk Factors | 6 | 2024 | 73809 | 0.040 |
Why?
|
Proteomics | 2 | 2010 | 3816 | 0.040 |
Why?
|
Aged, 80 and over | 5 | 2021 | 58683 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13961 | 0.040 |
Why?
|
Malaysia | 1 | 2018 | 105 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2690 | 0.040 |
Why?
|
Formularies as Topic | 1 | 2018 | 93 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 25956 | 0.030 |
Why?
|
Calibration | 1 | 2019 | 814 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1673 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10495 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1716 | 0.030 |
Why?
|
Adult | 5 | 2021 | 219935 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2284 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2016 | 20500 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2882 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2018 | 772 | 0.030 |
Why?
|
Awareness | 1 | 2017 | 644 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1754 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2021 | 80168 | 0.030 |
Why?
|
Canada | 1 | 2018 | 2111 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3099 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13245 | 0.020 |
Why?
|
Health Surveys | 1 | 2021 | 4064 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7225 | 0.020 |
Why?
|
Risk Assessment | 3 | 2019 | 23884 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2018 | 1404 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 58808 | 0.020 |
Why?
|
Sex Factors | 1 | 2023 | 10504 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3675 | 0.020 |
Why?
|
Isotopes | 1 | 2008 | 125 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5272 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 87892 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12721 | 0.020 |
Why?
|
Cost of Illness | 1 | 2017 | 1936 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9599 | 0.020 |
Why?
|
Isotope Labeling | 1 | 2008 | 392 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2024 | 64378 | 0.020 |
Why?
|
Computer Graphics | 1 | 2008 | 340 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7818 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8553 | 0.010 |
Why?
|
Prospective Studies | 2 | 2019 | 54137 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3211 | 0.010 |
Why?
|
Mass Screening | 1 | 2016 | 5427 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9304 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5816 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2008 | 6234 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9404 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 29557 | 0.010 |
Why?
|
Animals | 1 | 2010 | 167768 | 0.000 |
Why?
|
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_